期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

晚期氧化蛋白产物对血管平滑肌细胞单核细胞趋化蛋白-1表达的影响 被引量：4

The expression of monocyte chemotactic protein-1 induced by advanced oxidation protein products in smooth muscle cells
下载PDF
导出
摘要 目的研究晚期氧化蛋白产物对血管平滑肌细胞单核细胞趋化蛋白-1表达的影响。方法采用逆转录聚合酶链反应技术和酶联免疫吸附试验测定细胞中单核细胞趋化蛋白-1mRNA的表达量及蛋白的含量。观察晚期氧化蛋白产物对平滑肌细胞单核细胞趋化蛋白-1表达的影响。结果晚期氧化蛋白产物促进平滑肌细胞单核细胞趋化蛋白-1mRNA和蛋白表达的作用(P<0.01)。结论晚期氧化蛋白产物促进平滑肌细胞单核细胞趋化蛋白-1mRNA和蛋白表达可能是其致动脉粥样硬化机制之一。 Objective To study the expression of monocyte chemotactic protein-1（MCP-1） mRNA and protein induced by advanced oxidation protein products（AOPP ）in smooth muscle cells （SMCs）. Methods Reverse transcription polymerase chain reaction（RT-PCR）and enzyme-linked immunosorbent assay（ELISA）were adopted to measure expression of MCP-1 mRNA and protein. The effect of AOPP on the MCP-1 expression was observed. Results AOPP could enhance the expression of MCP-1 mRNA and protein inSMCs （P〈0. 01）. Conclusions It is possibly one of the atherosclerotic mechanisms that AOPP enhance the expression of MCP lmRNA and protein inSMCs.
作者 彭侃夫 吴雄飞 赵洪雯 孙岩 吴亿 王军霞
机构地区 第三军医大学西南医院肾科
出处 《中国血液净化》 2006年第5期252-255,共4页 Chinese Journal of Blood Purification
关键词 晚期氧化蛋白产物 单核细胞趋化蛋白-1 血管平滑肌细胞 动脉粥样硬化 Advanced oxidation protein products Monocyte chemotactic protein-1 Smooth muscle cells Atherosclerosis
分类号 R151.1 [医药卫生—营养与食品卫生学]
  • 相关文献

参考文献12

  • 1Witko-Sarsat V,Fedlander M.Capeiltere-BIandin C et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia.Kidney Int,1996,49(5):1304
  • 2袁方,刘尚喜,侯凡凡,陈瑗,田建伟,刘志强.晚期氧化蛋白产物导致血管内皮细胞氧化应激损伤[J].解放军医学杂志,2004,29(11):951-954. 被引量：20
  • 3Witko-Sarsat V,Friedlander M,Nguyen AT,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.J Immunol,1998,161(5):2524
  • 4Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32[SuPP13]:112-119
  • 5Ma KW,Greene EL,Reij L.Cardiovascular risk factors in chronic renal failure and hemodialysis populations.Am J Kid Dis,1992,19:505-513
  • 6K.B.Pomerantz,L.N.Fleisher,A.R.Tall and P.J.Cannon,Enrichment of endothelial cell arachidonateby lipid transfer from high density lipoproteins:Relationship to prostaglandin 12 synthesis.J.Lipid Res,1985,26:1269-1276
  • 7C.Thiermann,J.A.Mitchell and G.A.A.Ferns,Eicosanoids and atherosclerosis.Curr.Opin.Lipidol,1993,4:401-406
  • 8Descamps-Latscha -B,Jungers -P,Witko-Sarsat -V.Immune system dysregulation in uremia:Role of oxidative stress.BloodPurif,2002,20(5):481-484
  • 9Descamps-Latscha -B,Drueke -T,Witko-Sarsat -V.Dialysisinduced oxidative stress:Biological aspects,clinical consequences,and therapy.Semin-Dial,2001,14(3):193-199
  • 10Witko-Sarsat -V,Gausson V,Descamps-Latscha -B.Are advanced oxidation protein products potential toxins? Kidney Int Suppl,2003,(84):S11-14

二级参考文献17

  • 1[1]Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996, 49(5):1304
  • 2[2]Witko-Sarsat V, Friedlander M, Nguyen AT et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol,1998, 161(5):2524
  • 3[3]Witko-Sarsat V, Gausson V, Nguyen AT et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int, 2003, 64(1):82
  • 4[4]Kaneda H, Taguchi J, Ogasawara K et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 2002, 162(1):221
  • 5[5]Drueke T, Witko-Sarsat V, Massy Z et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation, 2002, 106(17):2212
  • 6[7]Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods, 1989, 119(2):203
  • 7[8]Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol, 1994, 55(2):253
  • 8[9]SX, Chen Y, Zhou M et al. Inhibitory effect of ebselen on the oxidation of low density lipoprotein. Redox Report, 1995,1:357
  • 9[10]Jungers P, Massy ZA, Khoa TN et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant, 1997,12(12):2597
  • 10[11]Descamps-Latscha B, Witko-Sarsat V. Oxidative stress in chronic renal failure and hemodialysis. Nephrologie, 2003,24(7):377-379

共引文献19

同被引文献71

引证文献4

二级引证文献15

中国血液净化
2006年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部